GlassScriptPhysician profile
Derrick N Raptis
NPI 1679749683
$25,024.33
in general payments reported to CMS, 2019-2025
44 companies · $1,871 in 2025
The $1,871 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,389 · 2020: $398 · 2021: $564 · 2022: $11K · 2023: $973 · 2024: $4,323 · 2025: $1,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,584 · Travel and Lodging: $1,583 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,584.08 |
| Travel and Lodging | $1,583.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,406.71 | 2022-2024 | Da Vinci Surgical System |
| E.R. Squibb & Sons, L.L.C. | $4,573.84 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,424.26 | 2019-2025 | Nucala, Trelegy Ellipta |
| Covidien LP | $935.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $641.24 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $518.70 | 2019-2025 | Ofev, Jascayd |
| Merck Sharp & Dohme LLC | $419.54 | 2019-2025 | Winrevair |
| Genzyme Corporation | $397.45 | 2022-2025 | |
| Grifols USA, LLC | $382.39 | 2020-2025 | Prolastin-C Liquid |
| Olympus America INC. | $298.61 | 2021-2025 | Spiration Valve System, Single-Use Flexible Video Bronchoscope |
| Actelion Pharmaceuticals US, INC. | $273.11 | 2019-2025 | Uptravi, Opsumit |
| Abbvie INC. | $262.16 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $261.85 | 2019-2025 | Tezspire, Breztri, Airsupra |
| Pulmonx Corporation | $219.39 | 2020-2022 | |
| Insmed, INC. | $215.58 | 2020-2025 | Arikayce |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $197.56 | 2022-2023 | Acthar |
| Janssen Pharmaceuticals, INC | $174.53 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $127.49 | 2019-2022 | |
| Ethicon INC. | $125.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.00 | 2023-2024 | |
| Mylan Specialty L.P. | $114.02 | 2023-2024 | Yupelri |
| United Therapeutics Corporation | $99.86 | 2022-2025 | Tyvaso, Orenitram |
| Alexion Pharmaceuticals, INC. | $73.75 | 2019 | |
| Verona Pharma, INC. | $72.82 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $63.11 | 2025 | Yupelri |
| Shionogi INC | $59.99 | 2021-2022 | |
| Philips North America LLC | $54.13 | 2022-2025 | Encore, (8874) Incourage |
| Genentech USA, INC. | $46.31 | 2019 | |
| Livanova USA, INC. | $46.22 | 2022 | |
| Gilead Sciences, INC. | $44.95 | 2021-2024 | |
| Baxter Healthcare | $44.47 | 2024 | Hillrom - Volara System, Hillrom - Monarch Airway Clearance System |
| Electromed, INC. | $41.62 | 2021-2023 | Smartvest |
| Ani Pharmaceuticals, INC. | $33.63 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $33.14 | 2025 | Tezspire |
| Lilly USA, LLC | $30.87 | 2025 | Zepbound |
| Allergan, INC. | $27.37 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $23.22 | 2019 | |
| Medtronic, INC. | $23.17 | 2021 | |
| Portola Pharmaceuticals, LLC | $22.98 | 2019 | |
| Vifor Pharma, INC. | $21.87 | 2024 | Zemaira |
| Advanced Respiratory, INC | $20.04 | 2020 | |
| Pfizer INC. | $19.77 | 2019 | |
| Inspire Medical Systems, INC. | $19.32 | 2024 | Inspire |
| Melinta Therapeutics, LLC | $13.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Raptis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.